Active Platelet Factor 4 (PF4)
CXCL4; SCYB4; Chemokine C-X-C-Motif Ligand 4; Oncostatin-A; Iroplact
- Product No.APA172Mu01
- Organism SpeciesMus musculus (Mouse) Same name, Different species.
- Buffer Formulation20mM Tris, 150mM NaCl, pH8.0, containing 1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose and Proclin300.
- Traits Freeze-dried powder
- Purity> 90%
- Isoelectric Point9.4
- ApplicationsCell culture; Activity Assays.
- DownloadInstruction Manual
- UOM 10µg50µg 200µg 1mg 5mg
For more details, please contact local distributors! 368 US$ 368
For more details, please contact local distributors! US$ 736
For more details, please contact local distributors! US$ 2208
For more details, please contact local distributors! US$ 5520
For more details, please contact local distributors!
Platelet factor 4 (PF4) is a small cytokine belonging to the CXC chemokine family that is also known as chemokine (C-X-C motif) ligand 4 (CXCL4). This chemokine is released from alpha-granules of activated platelets during platelet aggregation, and promotes blood coagulation by moderating the effects of heparin-like molecules. Due to these roles, it is predicted to play a role in wound repair and inflammation. To measure its ability to inhibit the FGF basic-dependent proliferation of HUVEC human umbilical vein endothelial cells, HUVEC cells were seeded into 96-well plates at a density of 3,000 cells/well with 2% serum standard DMEM including 1μg/mL recombinant human FGF1 and various concentrations of recombinant human PF4. After incubated for 48h, cells were observed by inverted microscope and cell proliferation was measured by Cell Counting Kit-8 (CCK-8). Briefly, 10µL of CCK-8 solution was added to each well of the plate, then the absorbance at 450nm was measured using a microplate reader after incubating the plate for 1-2 hours at 37℃. Proliferation of HUVEC cells after incubation with PF4 for 48h observed by inverted microscope was shown in Figure 1. Cell viability was assessed by CCK-8 (Cell Counting Kit-8) assay after incubation with recombinant human PF4 for 48h. The result was shown in Figure 2. It was obvious that PF4 significantly FGF basic-dependent proliferation of HUVEC cells. The ED50 is 3.4μg/mL.
(A)HUVEC cells cultured in DMEM with 1μg/mL FGF1, stimulated with 5μg/mL PF4 for 48h;
(B) Unstimulated HUVEC cells cultured in DMEM with 1μg/mL FGF1 for 48h.
Figure. Inhibition of HUVEC cells proliferation after stimulated with PF4.
Figure. Inhibition of FGF basic-dependent HUVEC proliferation after stimulated with PF4.
Reconstitute in 20mM Tris, 150mM NaCl (PH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
- BCA Protein Quantification Kit
- Molecular Mass Marker for Protein
- Monoclonal Antibody Customized Service
- Polyclonal Antibody Customized Service
- Protein Activity Test Experiment Service
- Electrophoretic Mobility Shift Assay (EMSA) Experiment Service
- Lentivirus Packaging Experiment Service
- Adenovirus Packaging Experiment Service
- Real Time PCR Experimental Service
- Spike RBD Protein (S-RBD)
- Protein G
- Protein A
|Biochimica et Biophysica Acta (BBA) - Proteins & Proteomics||Propofol lowers serum PF4 level and partially corrects hypercoagulopathy in endotoxemic rats PubMed: 20601223|
|Basic Research in Cardiology||Secretome of apoptotic peripheral blood cells (APOSEC) attenuates microvascular obstruction in a porcine closed chest reperfused acute myocardial infarction model: role of platelet aggregation and vasodilation PubMed: 22899170|
|PLoS One||Platelets Recognize Brain-Specific Glycolipid Structures, Respond to Neurovascular Damage and Promote Neuroinflammation PubMed: PMC3608633|
|Diving and Hyperbaric Medicine||Effect of splenectomy on platelet activation and decompression sickness outcome in a rat model of decompression Pubmed:25311322|
|Journal of Functional Foods||A Phellinus baumii–based supplement containing Salvia miltiorrhiza Bunge improves atherothrombotic profiles through endothelial nitric oxide synthase and cyclooxygenase pathwaysin vitro and in vivo science:S1756464616300676|
|Plos one||Aspirin, but Not Tirofiban Displays Protective Effects in Endotoxin Induced Lung Injury pubmed:27583400|
|international journal of molecular sciences||Evidence of the Role of R-Spondin 1 and Its Receptor Lgr4 in the Transmission of Mechanical Stimuli to Biological Signals for Bone Formation. pubmed:28272338|
|Experimental and Therapeutic Medicine||Feasibility of improving platelet‑rich plasma therapy by using chitosan with high platelet activation ability pubmed:28450960|
|Reproductive Toxicology||Aspirin pre-treatment modulates ozone-induced fetal growth restriction and alterations in uterine blood flow in rats Pubmed: 30528429|
|INTERNATIONAL JOURNAL OF CARDIOLOGY||Short and long-term changes in platelet and inflammatory biomarkers after cryoballoon and radiofrequency ablation Pubmed: 30857843|
|Available at SSRN 3335365||Evaluating the Platelet Activation Related to the Degradation of Biomaterials by Scheme of Molecular Markers|
|journal of biotechnology||Newly Identified HNP‐F from Human Neutrophil Peptide 1 Promotes Hemostasis Pubmed: 30927490|
|Data in Brief||Data for short and long-term prothrombotic biomarkers after cryoballoon and radiofrequency ablation|
|journal of thoracic and cardiovascular surgery||Evaluating Platelet Activation Related to the Degradation of Biomaterials Using Molecular Markers Pubmed: 32812629|
|Marine Drugs||The Inhibitory Effect of Protamine on Platelets is Attenuated by Heparin without Inducing Thrombocytopenia in Rodents Pubmed: 31533230|
|Thrombosis Research||Feasibility study of use of rabbit blood to evaluate platelet activation by medical devices Pubmed: 31838449|
|Nat Commun||The C5a/C5a receptor 1 axis controls tissue neovascularization through CXCL4 release from platelets 34099640|
|Vaccine||The effect of ChAdOx1 nCov-19 vaccine on arterial thrombosis development and platelet aggregation in female rats Pubmed:35183388|
|Catalog No.||Related products for research use of Mus musculus (Mouse) Organism species||Applications (RESEARCH USE ONLY!)|
|APA172Mu01||Active Platelet Factor 4 (PF4)||Cell culture; Activity Assays.|
|RPA172Mu01||Recombinant Platelet Factor 4 (PF4)||Positive Control; Immunogen; SDS-PAGE; WB.|
|RPA172Mu02||Recombinant Platelet Factor 4 (PF4)||Positive Control; Immunogen; SDS-PAGE; WB.|
|PAA172Mu01||Polyclonal Antibody to Platelet Factor 4 (PF4)||WB; IHC; ICC; IP.|
|PAA172Mu02||Polyclonal Antibody to Platelet Factor 4 (PF4)||WB; IHC; ICC; IP.|
|LAA172Mu71||Biotin-Linked Polyclonal Antibody to Platelet Factor 4 (PF4)||WB; IHC; ICC.|
|LAA172Mu81||FITC-Linked Polyclonal Antibody to Platelet Factor 4 (PF4)||WB; IHC; ICC; IF.|
|SEA172Mu||ELISA Kit for Platelet Factor 4 (PF4)||Enzyme-linked immunosorbent assay for Antigen Detection.|
|SCA172Mu||CLIA Kit for Platelet Factor 4 (PF4)||Chemiluminescent immunoassay for Antigen Detection.|
|LMA172Mu||Magnetic Luminex Assay Kit for Platelet Factor 4 (PF4) ,etc.||Magnetic Luminex Assay for Antigen Detection.|
|KSA172Mu01||ELISA Kit DIY Materials for Platelet Factor 4 (PF4)||Main materials for "Do It (ELISA Kit) Yourself".|